PRESS RELEASE published on 07/25/2025 at 18:30, 1 year ago Informations privilégiées / Communiqué sur comptes, résultats Theraclion annonce une progression significative au premier semestre 2025, avec une hausse des ventes de consommables, l'expansion en Bulgarie et Espagne, l'accélération de la commercialisation et des avancées dans l'essai clinique FDA FDA Commercialisation Ventes Progression Theraclion
BRIEF published on 07/09/2025 at 18:35, 1 year 1 month ago Review of the first half of 2025 of the Theraclion liquidity contract Liquidity Contract Half-yearly Report Euronext Growth Theraclion Securities Traded
BRIEF published on 07/09/2025 at 18:35, 1 year 1 month ago Bilan du premier semestre 2025 du contrat de liquidité de Theraclion Contrat De Liquidité Bilan Semestriel Euronext Growth Theraclion Titres Échangés
PRESS RELEASE published on 07/09/2025 at 18:30, 1 year 1 month ago Informations privilégiées / Autres communiqués Présentation du bilan du premier semestre 2025 du contrat de liquidité entre Theraclion et le Crédit Industriel et Commercial, incluant les chiffres clés des transactions. Informations sur Theraclion, société de MedTech développant une alternative non invasive à la chirurgie Contrat De Liquidité MedTech Bilan SONOVEIN Ultrasons Focalisés
BRIEF published on 02/20/2025 at 18:35, 1 year 5 months ago Theraclion sécurise un financement via un emprunt obligataire convertible Financement Obligations Convertibles Stratégie Commerciale Theraclion R&D Et FDA
BRIEF published on 02/20/2025 at 18:35, 1 year 5 months ago Theraclion secures financing via a convertible bond issue Convertible Bonds Funding Business Strategy Theraclion R&D And FDA
PRESS RELEASE published on 02/20/2025 at 18:30, 1 year 5 months ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Theraclion sécurise un financement de 6 millions d'euros auprès de ses actionnaires historiques grâce à un emprunt obligataire convertible. Objectif : poursuite R&D et développement commercial Actionnaires Financement Emprunt Theraclion Obligataire Convertible
PRESS RELEASE published on 02/20/2025 at 18:30, 1 year 5 months ago Inside Information / Operations of the issuer (acquisitions, sales...) Theraclion secures financing of €6 million through a convertible bond loan with firm commitments from historical shareholders, Furui and Unigestion. CEO Martin Deterre highlights strategic priorities for revenue growth and FDA approval Financing Strategic Priorities FDA Approval Theraclion Convertible Bond Loan
BRIEF published on 02/07/2025 at 18:35, 1 year 6 months ago Publication of Theraclion's adjusted accounts for the first half of 2024 Treasury Theraclion Adjusted Accounts Focused Ultrasound Varicose Veins Walk
BRIEF published on 02/07/2025 at 18:35, 1 year 6 months ago Publication des comptes ajustés de Theraclion pour le premier semestre 2024 Trésorerie Theraclion Comptes Ajustés Ultrasons Focalisés Marche Des Varices
Published on 08/15/2026 at 00:50, 11 hours 14 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 11 hours 49 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 12 hours 19 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 12 hours 39 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 13 hours 4 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/15/2026 at 08:05, 3 hours 59 minutes ago SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:15, 17 hours 49 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 19 hours 59 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/13/2026 at 18:00, 1 day 18 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 18 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 18 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 18 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 18 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026